van Oijen MGH - Search Results

1

From presentation to paper: Gender disparities in oncological research.

Dijksterhuis WPM, Stroes CI, Tan WL, Ithimakin S, Calles A, van Oijen MGH, Verhoeven RHA, Barriuso J, Oosting SF, Ivankovic DK, Furness AJS, Bozovic-Spasojevic I, Gomez-Roca C, van Laarhoven HWM. Dijksterhuis WPM, et al. Among authors: van oijen mgh, van laarhoven hwm. Int J Cancer. 2020 Jun 1;146(11):3011-3021. doi: 10.1002/ijc.32660. Epub 2019 Oct 11. Int J Cancer. 2020. PMID: 31472016 Free PMC article.

2

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent.

Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW. Haj Mohammad N, et al. Support Care Cancer. 2015 Dec;23(12):3589-98. doi: 10.1007/s00520-015-2727-4. Epub 2015 Apr 18. Support Care Cancer. 2015. PMID: 25894882 Free PMC article.

3

Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis.

Mohammad NH, ter Veer E, Ngai L, Mali R, van Oijen MG, van Laarhoven HW. Mohammad NH, et al. Cancer Metastasis Rev. 2015 Sep;34(3):429-41. doi: 10.1007/s10555-015-9576-y. Cancer Metastasis Rev. 2015. PMID: 26267802 Free PMC article. Review.

4

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.

Ter Veer E, Mohammad NH, Lodder P, Ngai LL, Samaan M, van Oijen MG, van Laarhoven HW. Ter Veer E, et al. Gastric Cancer. 2016 Jul;19(3):696-712. doi: 10.1007/s10120-015-0587-8. Epub 2016 Jan 11. Gastric Cancer. 2016. PMID: 26754295 Free PMC article. Review.

5

S-1 with leucovorin and oxaliplatin for advanced gastric cancer.

Ter Veer E, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: van oijen mgh, van laarhoven hwm. Lancet Oncol. 2016 Feb;17(2):e41. doi: 10.1016/S1470-2045(16)00005-X. Lancet Oncol. 2016. PMID: 26868348 No abstract available.

6

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.

Ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RM, van Oijen MG, van Laarhoven HW. Ter Veer E, et al. Cancer Metastasis Rev. 2016 Sep;35(3):439-56. doi: 10.1007/s10555-016-9632-2. Cancer Metastasis Rev. 2016. PMID: 27417221 Free PMC article. Review.

7

The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.

Ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RMA, Anderegg MC, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: van oijen mgh, van laarhoven hwm, van valkenhoef g. J Natl Cancer Inst. 2016 Aug 30;108(10). doi: 10.1093/jnci/djw166. Print 2016 Oct. J Natl Cancer Inst. 2016. PMID: 27576566 Review.

8

Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.

Haj Mohammad N, Bernards N, van Putten M, Lemmens VEPP, van Oijen MGH, van Laarhoven HWM. Haj Mohammad N, et al. Among authors: van oijen mgh, van laarhoven hwm, van putten m. Eur J Cancer. 2017 Jun;78:28-36. doi: 10.1016/j.ejca.2017.03.008. Epub 2017 Apr 14. Eur J Cancer. 2017. PMID: 28412586

9

Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.

Ter Veer E, Ngai LL, Valkenhoef GV, Mohammad NH, Anderegg MCJ, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: van oijen mgh, van laarhoven hwm. Sci Rep. 2017 Aug 2;7(1):7142. doi: 10.1038/s41598-017-07750-3. Sci Rep. 2017. PMID: 28769123 Free PMC article.

10

Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.

Creemers A, Krausz S, Strijker M, van der Wel MJ, Soer EC, Reinten RJ, Besselink MG, Wilmink JW, van de Vijver MJ, van Noesel CJM, Verheij J, Meijer SL, Dijk F, Bijlsma MF, van Oijen MGH, van Laarhoven HWM. Creemers A, et al. Among authors: van der wel mj, van oijen mgh, van laarhoven hwm, van de vijver mj, van noesel cjm. Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):394-403. doi: 10.1016/j.bbcan.2017.08.002. Epub 2017 Aug 8. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28801248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page